These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 24170313

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. TLR4 regulates IFN-γ and IL-17 production by both thymic and induced Foxp3+ Tregs during intestinal inflammation.
    Cao AT, Yao S, Stefka AT, Liu Z, Qin H, Liu H, Evans-Marin HL, Elson CO, Nagler CR, Cong Y.
    J Leukoc Biol; 2014 Nov; 96(5):895-905. PubMed ID: 25015957
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Development of thymic Foxp3(+) regulatory T cells: TGF-β matters.
    Chen W, Konkel JE.
    Eur J Immunol; 2015 Apr; 45(4):958-65. PubMed ID: 25684698
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM.
    J Exp Med; 2003 Dec 15; 198(12):1875-86. PubMed ID: 14676299
    [Abstract] [Full Text] [Related]

  • 29. Induced CD4+Foxp3+ regulatory T cells in immune tolerance.
    Bilate AM, Lafaille JJ.
    Annu Rev Immunol; 2012 Dec 15; 30():733-58. PubMed ID: 22224762
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Human CD4+ HLA-G+ regulatory T cells are potent suppressors of graft-versus-host disease in vivo.
    Pankratz S, Bittner S, Herrmann AM, Schuhmann MK, Ruck T, Meuth SG, Wiendl H.
    FASEB J; 2014 Aug 15; 28(8):3435-45. PubMed ID: 24744146
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis.
    Delgoffe GM, Woo SR, Turnis ME, Gravano DM, Guy C, Overacre AE, Bettini ML, Vogel P, Finkelstein D, Bonnevier J, Workman CJ, Vignali DA.
    Nature; 2013 Sep 12; 501(7466):252-6. PubMed ID: 23913274
    [Abstract] [Full Text] [Related]

  • 38. Alternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis.
    Haribhai D, Ziegelbauer J, Jia S, Upchurch K, Yan K, Schmitt EG, Salzman NH, Simpson P, Hessner MJ, Chatila TA, Williams CB.
    J Immunol; 2016 Apr 15; 196(8):3305-17. PubMed ID: 26927797
    [Abstract] [Full Text] [Related]

  • 39. Human regulatory T-cell development is dictated by Interleukin-2 and -15 expressed in a non-overlapping pattern in the thymus.
    Caramalho I, Nunes-Silva V, Pires AR, Mota C, Pinto AI, Nunes-Cabaço H, Foxall RB, Sousa AE.
    J Autoimmun; 2015 Jan 15; 56():98-110. PubMed ID: 25481744
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.